Primary hepatic carcinoid: A case report and literature review

World Journal of Gastroenterology

Volumn 15, Issue 19, 2009, Pages 2418-2422

  Fenoglio, Luigi Maria ^a   Severini, Sara ^a   Ferrigno, Domenico ^a   Gollè, Giovanni ^a   Serraino, Cristina ^a   Bracco, Christian ^a   Castagna, Elisabetta ^a   Brignone, Chiara ^a   Pomero, Fulvio ^a   Migliore, Elena ^a   David, Ezio ^b   Salizzoni, Mauro ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Carcinoid; Neuroendocrine neoplasm; Primary hepatic carcinoid; Prognosis; Surgical treatment; Therapy

Indexed keywords

KI 67 ANTIGEN; OCTREOTIDE; PROTEIN S 100; SYNAPTOPHYSIN;

AGED; ANGIONEUROTIC EDEMA; APPENDECTOMY; ARTICLE; BILE DUCT DILATATION; CANCER GRADING; CARCINOID; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FACE EDEMA; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; TUMOR VOLUME;

EID: 67651241848     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2418     Document Type: Article

References (29)

1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-1068
2. Giovanella L. Tumori neuroendocrini: diagnosi e fisiopatologia clinica. Genova: Medical Systems, 1999: 7-102
3. Harpole DH Jr, Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg 1992; 54: 50-54; discussion 54-55
4. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240: 117-122
5. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717-1751
6. Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg 2004; 239: 210-219
7. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072
8. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998; 352: 799-805
9. Edmondson HA. Carcinoid tumor. In: Edmondson HA. Tumors of the liver and intrahepatic bile ducts (Atlas of Tumor Pathology). Washington: Armed Forces Institute of Pathology, 1958: 105-111
10. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959
11. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg 2005; 29: 92-101
12. Staren ED, Gould VE, Warren WH, Wool NL, Bines S, Baker J, Bonomi P, Roseman DL, Economou SG. Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery 1988; 104: 1080-1089
13. Oberg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab 2005; 19: 265-276
14. Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, Moser E, Nitzsche E. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220: 373-380
15. Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, Langstrom B, Bergstrom M, Eriksson B. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005; 90: 3392-3400
16. Shi W, Johnston CF, Buchanan KD, Ferguson WR, Laird JD, Crothers JG, McIlrath EM. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM 1998; 91: 295-301
17. Sundin A, Eriksson B, Bergström M, Långström B, Oberg K, Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci 2004; 1014: 246-257
18. Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, Nishi H, Taguchi KI, Kotoh K, Nawata H. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001; 7: 746-750
19. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003; 10: 1171-1175
20. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987; 5: 1502-1522
21. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108: 1091-1096
22. Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO, Krenning EP. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 2008; 26: 2124-2130
23. Yao JC, Vauthey JN. Primary and metastatic hepatic carcinoid: is there an algorithm? Ann Surg Oncol 2003; 10: 1133-1135
24. Rohaizak M, Farndon JR. Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours. ANZ J Surg 2002; 72: 635-638
25. Bax ND, Woods HF, Batchelor A, Jennings M. Octreotide therapy in carcinoid disease. Anticancer Drugs 1996; 7 Suppl 1: 17-22
26. Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y, Kelsen D. Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer 1993; 72: 244-248
27. Faiss S, Räth U, Mansmann U, Caird D, Clemens N, Riecken EO, Wiedenmann B. Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors. Digestion 1999; 60: 469-476
28. Nikfarjam M, Muralidharan V, Christophi C. Primary hepatic carcinoid tumours. HPB (Oxford) 2004; 6: 13-17
29. Iimuro Y, Deguchi Y, Ueda Y, Tanaka A, Iwasa Y, Ishihara M, Mizuta K, Yamamoto Y, Ikai I, Shimahara Y, Yamaoka Y. Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol 2002; 17: 1119-1124